One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi.
Gendrel
D
D
Hôpital Saint Vincent de Paul, Paris, France.
Moreno
J L
JL
Nduwimana
M
M
Baribwira
C
C
Raymond
J
J
D000284:Administration, Oral; D000293:Adolescent; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002063:Burundi / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D004405:Dysentery, Bacillary / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005243:Feces / Q000382:microbiology; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D015366:Pefloxacin / Q000008:administration & dosage* / Q000627:therapeutic use*; D012762:Shigella dysenteriae
D000890:Anti-Infective Agents; D015366:Pefloxacin